NL7605405A - Werkwijze voor het bereiden van farmacologisch actieve verbindingen. - Google Patents

Werkwijze voor het bereiden van farmacologisch actieve verbindingen.

Info

Publication number
NL7605405A
NL7605405A NL7605405A NL7605405A NL7605405A NL 7605405 A NL7605405 A NL 7605405A NL 7605405 A NL7605405 A NL 7605405A NL 7605405 A NL7605405 A NL 7605405A NL 7605405 A NL7605405 A NL 7605405A
Authority
NL
Netherlands
Prior art keywords
procedure
active compounds
pharmacologically active
preparing pharmacologically
preparing
Prior art date
Application number
NL7605405A
Other languages
English (en)
Dutch (nl)
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB21817/75A external-priority patent/GB1553070A/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of NL7605405A publication Critical patent/NL7605405A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms
NL7605405A 1975-05-21 1976-05-20 Werkwijze voor het bereiden van farmacologisch actieve verbindingen. NL7605405A (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB21817/75A GB1553070A (en) 1975-05-21 1975-05-21 Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
GB4778275 1975-11-20

Publications (1)

Publication Number Publication Date
NL7605405A true NL7605405A (nl) 1976-11-23

Family

ID=26255540

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7605405A NL7605405A (nl) 1975-05-21 1976-05-20 Werkwijze voor het bereiden van farmacologisch actieve verbindingen.

Country Status (13)

Country Link
US (6) US4098898A (xx)
JP (1) JPS51141865A (xx)
AT (1) AT356131B (xx)
AU (1) AU503525B2 (xx)
CA (1) CA1076581A (xx)
CH (2) CH626883A5 (xx)
DE (1) DE2621834A1 (xx)
DK (1) DK145541C (xx)
FR (1) FR2311536A1 (xx)
IE (1) IE44062B1 (xx)
IL (1) IL49528A (xx)
NL (1) NL7605405A (xx)
SE (1) SE419544B (xx)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170652A (en) * 1974-03-12 1979-10-09 Smith Kline & French Laboratories Limited Heterocyclic-methylthioalkyl-guanidines
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
ATE6156T1 (de) * 1978-10-16 1984-02-15 Imperial Chemical Industries Plc Verzweigtkettige heterozyklische guanidinderivate mit antisekretorischer wirkung, verfahren zu ihrer herstellung, zwischenprodukte und die genannten derivate enthaltende pharmazeutische zusammensetzungen.
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
JPS568357A (en) * 1979-02-16 1981-01-28 Eisai Co Ltd Cyanoguanidine derivative and its production
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4315024A (en) * 1980-08-08 1982-02-09 Cooper Laboratories, Inc. Compositions and method for treating red eye
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4443456A (en) * 1981-05-12 1984-04-17 William H. Rorer, Inc. Pyridyl alkylene amidinoureas
US4810717A (en) * 1981-11-12 1989-03-07 E. I. Du Pont De Nemours And Company 2-hydroxypropylamine aryl ester derivatives
DE3232462A1 (de) * 1982-09-01 1984-03-01 Bayer Ag, 5090 Leverkusen 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4795719A (en) * 1984-05-15 1989-01-03 Waferscale Integration, Inc. Self-aligned split gate eprom process
DE3579000D1 (de) * 1985-04-02 1990-09-06 Heumann Pharma Gmbh & Co Imidazolylalkylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
NL8601585A (nl) * 1986-06-19 1988-01-18 Vereniging Voor Christelijk Wetenschappelijk Onderwijs N-(2-gesubstitueerde alkyl)-n-imidazol-4-yl alkyl guanidine.
DE3631334A1 (de) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4996221A (en) * 1987-01-13 1991-02-26 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives as immune modulators
US5229386A (en) * 1989-01-05 1993-07-20 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
US5145860A (en) * 1989-01-05 1992-09-08 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds and pharmaceutical composition comprising the same
CA2104946A1 (en) * 1991-02-27 1992-08-28 Hendrik Timmerman Imidazole-derivatives having agonistic or antagonistic activity on the histamine h3-receptor
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
WO1993014753A1 (en) * 1992-01-27 1993-08-05 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives and methods for their use
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions
CN1319007A (zh) 1998-09-22 2001-10-24 石原产业株式会社 含有硝基乙烯胺衍生物或其盐作为有效成分的医药组合物
GB0404434D0 (en) * 2004-02-27 2004-03-31 Novartis Ag Organic compounds
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868457A (en) * 1969-10-29 1975-02-25 Smith Kline French Lab Method of inhibiting histamine activity with guanidine compounds
GB1305549A (xx) * 1969-10-29 1973-02-07
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3808336A (en) * 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
US4000302A (en) * 1972-04-20 1976-12-28 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
US4000296A (en) * 1972-09-05 1976-12-28 Smith Kline & French Laboratories Limited Imidazole alkylguanidine compounds
US3979398A (en) * 1973-02-08 1976-09-07 Smith Kline & French Laboratories Limited Sulphoxides
US4124717A (en) * 1973-05-17 1978-11-07 Smith Kline & French Laboratories Limited Thiazolyl alkylaminoethylene compounds
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4046907A (en) * 1973-05-17 1977-09-06 Smith Kline & French Laboratories Limited Imidazole alkylaminoethylene compounds
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups
US4152443A (en) * 1973-07-13 1979-05-01 Smith Kline & French Laboratories Limited Imidazolyl thioureas, ureas and guanidines
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas
US4107319A (en) * 1974-03-12 1978-08-15 Smith Kline & French Laboratories Limited Pharmacologically active compounds
US4013769A (en) * 1974-05-09 1977-03-22 Smith Kline & French Laboratories Limited Pyridyl-alkylaminoethylene compounds
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
US4093621A (en) * 1974-09-02 1978-06-06 Smith Kline & French Laboratories Limited Process for preparing heterocyclicalkylthioalkyl-N-cyanoguanidines and thioureas
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4156727A (en) * 1975-07-31 1979-05-29 Smith Kline & French Laboratories Limited Alkoxy pyridine compounds
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
ZA782129B (en) * 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives

Also Published As

Publication number Publication date
IL49528A (en) 1980-11-30
US4440775A (en) 1984-04-03
IE44062B1 (en) 1981-08-12
US4333946A (en) 1982-06-08
CH624941A5 (xx) 1981-08-31
AU503525B2 (en) 1979-09-06
US4098898A (en) 1978-07-04
FR2311536A1 (fr) 1976-12-17
US4347250A (en) 1982-08-31
CA1076581A (en) 1980-04-29
ATA361576A (de) 1979-09-15
DK145541C (da) 1983-05-16
DE2621834A1 (de) 1976-12-02
US4247558A (en) 1981-01-27
SE7605620L (sv) 1976-11-22
IL49528A0 (en) 1976-07-30
JPS51141865A (en) 1976-12-07
AT356131B (de) 1980-04-10
IE44062L (en) 1976-11-21
AU1419576A (en) 1977-11-24
DK206576A (da) 1976-11-22
CH626883A5 (xx) 1981-12-15
DK145541B (da) 1982-12-06
US4276301A (en) 1981-06-30
SE419544B (sv) 1981-08-10
FR2311536B1 (xx) 1979-03-23

Similar Documents

Publication Publication Date Title
NL7605405A (nl) Werkwijze voor het bereiden van farmacologisch actieve verbindingen.
NL7510344A (nl) Werkwijze voor het bereiden van farmacologisch actieve verbindingen.
NL7611027A (nl) Werkwijze voor het bereiden van 2-azetidonine- -verbindingen.
NL7506951A (nl) Werkwijze voor het bereiden van farmacologisch werkzame verbindingen.
NL7603216A (nl) Werkwijze voor het bereiden van hydroxybenzalde- hyden.
NL7600163A (nl) Werkwijze voor het carbonyleren van arylalkylha- logeniden.
NL7609917A (nl) Werkwijze voor het bereiden van farmacologisch actieve middelen.
NL7608777A (nl) Werkwijze voor het bereiden van chromanonen-4.
NL7607272A (nl) Werkwijze voor het bereiden van farmacologisch werkzame complexen.
NL7606120A (nl) Werkwijze voor de bereiding van farmacologisch werkzame heteroarylderivaten.
NL7604621A (nl) Werkwijze voor het bereiden van 3-methylpyri- dine.
NL7608383A (nl) Werkwijze voor het bereiden van gesubstitueerde imidazolen.
NL7604063A (nl) Werkwijze voor het bereiden van 1.1.1.-triaryl- alkylaminen.
NL7608749A (nl) Werkwijze voor het bereiden van benzimidazool- -carbamaten.
NL7502935A (nl) Werkwijze voor het bereiden van farmacologisch actieve verbindingen.
NL7614024A (nl) Werkwijze voor het bereiden van 4-androsteen- -3,17-dion-derivaten.
NL7603651A (nl) Werkwijze voor het bereiden van 3.4-dihydrospiro- -2h-1.3-benzooxazinen.
NL7606178A (nl) Werkwijze voor de bereiding van farmacologisch actieve heteroarylderivaten.
NL7605411A (nl) Werkwijze voor het bereiden van het antibioticum lucknomycine.
NL7608505A (nl) Werkwijze voor het bereiden van farmacologisch actieve materialen.
NL7609995A (nl) Werkwijze voor het bereiden van hydrazine-hy- draatoplossingen.
NL7613307A (nl) Werkwijze voor het bereiden van 2(1h)-chinazo- linonderivaten.
NL7605202A (nl) Werkwijze voor het bereiden van 2-aryl-2h-benzo- triazolen.
NL7608832A (nl) Werkwijze voor het bereiden van hydrazinen.
NL7602101A (nl) Werkwijze voor het bereiden van 4-oxo-hexahy- dro-pyrazinoisochinolinederivaten.

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BV The patent application has lapsed